{"id":"https://openalex.org/W2986366154","doi":"https://doi.org/10.1182/blood-2019-131324","title":"The JAK1/2 Inhibitor Ruxolitinib Downregulates CXCL12 Secretion from Bone Marrow Stromal Cells and M2 Macrophage Polarization in Multiple Myeloma","display_name":"The JAK1/2 Inhibitor Ruxolitinib Downregulates CXCL12 Secretion from Bone Marrow Stromal Cells and M2 Macrophage Polarization in Multiple Myeloma","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2986366154","doi":"https://doi.org/10.1182/blood-2019-131324","mag":"2986366154"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-131324","doi":"https://doi.org/10.1182/blood-2019-131324","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-131324","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100678209","display_name":"Haiming Chen","orcid":"https://orcid.org/0000-0003-4279-2459","observed_orcids":["https://orcid.org/0000-0003-4279-2459"]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haiming Chen","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100416268","display_name":"Mingjie Li","orcid":"https://orcid.org/0000-0003-3470-1844","observed_orcids":["https://orcid.org/0000-0003-3470-1844"]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mingjie Li","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090300095","display_name":"Eric Sanchez","orcid":"https://orcid.org/0000-0001-8656-3717","observed_orcids":["https://orcid.org/0000-0001-8656-3717"]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Sanchez","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005921558","display_name":"Nicole Ng","orcid":"https://orcid.org/0000-0001-6614-4427","observed_orcids":["https://orcid.org/0000-0001-6614-4427"]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Ng","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067697546","display_name":"Erin Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Yu","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084603634","display_name":"Sean Elliott Bujarski","orcid":"https://orcid.org/0009-0006-7994-7660","observed_orcids":["https://orcid.org/0009-0006-7994-7660"]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean Bujarski","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043971551","display_name":"Zhengyi Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhengyi Yin","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037938627","display_name":"Tara Hekmati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tara Hekmati","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017761899","display_name":"Dylan Field","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dylan Field","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030049458","display_name":"Jasper Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jasper Wang","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042812937","display_name":"Isabella Nassir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isabella Nassir","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108042405","display_name":"Justin C. Huang","orcid":"https://orcid.org/0000-0002-6596-5781","observed_orcids":["https://orcid.org/0000-0002-6596-5781"]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Huang","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029284830","display_name":"David Daniely","orcid":"https://orcid.org/0000-0001-7403-0198","observed_orcids":["https://orcid.org/0000-0001-7403-0198"]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Daniely","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Cathy S. Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cathy S. Wang","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102805482","display_name":"Ning Xu","orcid":"https://orcid.org/0000-0003-1590-9359","observed_orcids":["https://orcid.org/0000-0003-1590-9359"]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ning Xu","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040835019","display_name":"James R. Berenson","orcid":"https://orcid.org/0000-0003-1587-6104","observed_orcids":["https://orcid.org/0000-0003-1587-6104"]},"institutions":[{"id":"https://openalex.org/I4210151813","display_name":"Institute for Myeloma & Bone Cancer Research","ror":"https://ror.org/04xwmf991","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210151813"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James R. Berenson","raw_affiliation_strings":["Institute for Myeloma & Bone Cancer Research, West Hollywood, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Myeloma & Bone Cancer Research, West Hollywood, CA","institution_ids":["https://openalex.org/I4210151813"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210151813"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"4352","last_page":"4352"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9670000076293945},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9350000023841858},{"id":"https://openalex.org/keywords/b7-h3","display_name":"B7-H3","score":0.8840000033378601},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8500000238418579},{"id":"https://openalex.org/keywords/jak1-2-inhibition","display_name":"JAK1/2 inhibition","score":0.9039999842643738},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.8420000076293945},{"id":"https://openalex.org/keywords/m2-macrophage-polarization","display_name":"M2 macrophage polarization","score":0.9900000095367432},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7089999914169312},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.8399999737739563},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.699999988079071},{"id":"https://openalex.org/keywords/cd8","display_name":"CD8","score":0.6510000228881836},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6449999809265137},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.49399998784065247},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.7068414092063904},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6966155767440796},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5882529020309448},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.5212301015853882},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44143056869506836},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.43300390243530273},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.4110088348388672},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4086892306804657},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35102295875549316},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.349639892578125},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3033181130886078},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.20888707041740417},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.08164867758750916}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-131324","doi":"https://doi.org/10.1182/blood-2019-131324","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-131324","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2987555609","https://openalex.org/W4310093486","https://openalex.org/W3115962838","https://openalex.org/W7203530559","https://openalex.org/W2778283111","https://openalex.org/W3155570747","https://openalex.org/W7120325785","https://openalex.org/W2969916059","https://openalex.org/W2692323761","https://openalex.org/W4391530351"],"abstract_inverted_index":{"Introduction:":[0],"The":[1,18,143,398,413],"JAKSTAT":[2],"pathway":[3,20,40],"plays":[4],"a":[5,43],"critical":[6],"role":[7],"in":[8,24,31,57,66,96,128,183,201,209,221,230,232,243,258,310,323,349,372,374,389,405,407,427,429,450],"the":[9,38,58,86,89,259,288,380,438,451],"regulation":[10],"of":[11,37,88,379,395],"hematopoietic":[12],"pathways":[13],"and":[14,28,61,99,135,147,153,161,171,239,283,319,345,421,424],"immunological":[15,363],"cytokine":[16,364],"signaling.":[17,365],"JAK":[19,39],"is":[21,52,403],"also":[22,342],"involved":[23],"tumor":[25,74],"cell":[26,305,338],"proliferation":[27],"drug":[29],"resistance":[30],"multiple":[32],"myeloma":[33,308],"(MM).":[34],"Thus,":[35],"inhibition":[36],"should":[41],"be":[42,392],"potentially":[44,301,445],"effective":[45],"strategy":[46],"for":[47,435],"treating":[48],"MM":[49,109,121,184,236,261],"patients.":[50,412],"B7-H3":[51,95,207,228,256,273,296,402,419,442],"an":[53],"immune":[54,79,399,439],"checkpoint":[55,70,400,440],"protein":[56,275,401,441],"B7":[59],"superfamily":[60],"has":[62],"been":[63,126],"shown":[64,278],"overexpressed":[65,404],"several":[67],"tumors.":[68],"Immune":[69],"blockade":[71,297],"may":[72,361,391,444],"suppress":[73],"progression":[75],"or":[76,150,187,192,196],"enhance":[77],"anti-tumor":[78],"responses.":[80],"In":[81,269],"this":[82],"study,":[83],"we":[84,293],"investigated":[85],"effects":[87],"JAK1/2":[90,414],"inhibitor":[91,415],"ruxolitinib":[92],"(Rux)":[93],"on":[94],"MM.":[97],"Materials":[98],"Methods:":[100],"Bone":[101],"marrow":[102],"mononuclear":[103],"cells":[104,138,144,191,194,237,249,309,357,388],"(BMMCs)":[105],"were":[106,117,139,145],"collected":[107],"from":[108,119,141,211,241],"patients":[110,212,217,233,242],"after":[111,251],"obtaining":[112],"IRB":[113],"approval.":[114],"Single-cell":[115],"suspensions":[116],"prepared":[118],"human":[120,260],"LAG\u03bb-1A":[122,264],"xenografts":[123],"which":[124,383,443],"had":[125],"grown":[127],"severe":[129],"combined":[130],"immunodeficient":[131],"mice.":[132],"HS-5":[133],"stromal":[134,190,248],"SUP-T1":[136],"T":[137,193,304,356,387],"purchased":[140],"ATCC.":[142],"cultured":[146,266],"treated":[148],"with":[149,189,195,213,234,247,279,287,325,335,355],"without":[151,197],"RUX":[152],"then":[154],"subjected":[155],"to":[156,173,219,410],"qRT-PCR,":[157,166],"flow":[158,280],"cytometric":[159,281],"analysis,":[160],"western":[162,284],"blot":[163],"analysis.":[164],"For":[165],"total":[167],"RNA":[168],"was":[169,181,353],"extracted":[170],"applied":[172],"cDNA":[174],"synthesis,":[175],"followed":[176],"by":[177,298],"qPCR.":[178],"Gene":[179],"expression":[180,208,229,257,290,322,348,371,420,426],"analyzed":[182],"BMMCs":[185],"alone":[186],"co-cultured":[188,246],"Rux":[198,225,254,271,299,315,341,360,384,416,436],"treatment":[199],"(1\u03bcM)":[200],"vitro.":[202,430],"Results:":[203],"We":[204,312],"identified":[205],"increased":[206,368],"MMBMMCs":[210,231],"progressive":[214],"disease":[215],"(PD)":[216],"compared":[218,409],"those":[220,334],"complete":[222],"remission":[223],"(CR).":[224],"significantly":[226],"reduced":[227],"PD,":[235],"(U266),":[238],"BM":[240,350,428],"PD":[244,408],"when":[245,265,351],"(HS-5)":[250],"48-72":[252],"hours.":[253],"decreased":[255],"xenograft":[262],"model":[263],"ex":[267],"vivo.":[268],"addition,":[270],"suppressed":[272],"at":[274],"levels":[276],"as":[277],"analysis":[282],"blotting,":[285],"consistent":[286],"gene":[289,321,347,370],"results.":[291],"Next,":[292],"tested":[294],"whether":[295],"could":[300],"restore":[302,446],"exhausted":[303,447],"activity":[306,449],"against":[307],"MMBM.":[311],"found":[313],"that":[314,377],"can":[316,417],"increase":[317,422],"IL-2":[318,344,423],"CD8":[320,346,369,386,425],"MMBM":[324,373,390,406,452],"lower":[326],"plasma":[327,337],"percentages":[328,339],"(<":[329],"30%)":[330],"but":[331],"not":[332],"among":[333],"higher":[336],"(>70%).":[340],"elevated":[343],"it":[352],"cocultured":[354],"(SUP-T1),":[358],"suggesting":[359,376],"mediate":[362],"B7-H3-neutralizing":[366],"antibody":[367],"vitro,":[375],"one":[378],"mechanisms":[381],"through":[382],"upregulates":[385],"via":[393],"downregulation":[394],"B7-H3.":[396],"Conclusion:":[397],"CR":[411],"decrease":[418],"Our":[431],"results":[432],"provide":[433],"evidence":[434],"inhibiting":[437],"T-cell":[448],"tumoral":[453],"microenvironment.":[454],"Disclosures":[455],"Chen:":[456],"Oncotraker":[457],"Inc:":[458],"Equity":[459,462,467],"Ownership.":[460],"Berenson:OncoTracker:":[461],"Ownership,":[463,468],"Other:":[464,469],"Officer;":[465,470],"OncoTracker:":[466],"Bristol-Myers":[471,476],"Squibb:":[472,477],"Honoraria,":[473,478],"Research":[474,479,484,489],"Funding;":[475,480,485,490],"Incyte":[481,486],"Corporation.:":[482,487],"Consultancy,":[483,488,492,496,500,504,508,512,516,520],"Takeda:":[491,495],"Speakers":[493,497,501,505,509,513,517,521],"Bureau;":[494,498,502,506,510,514,518,522],"Janssen:":[499,503],"Amag:":[507,511],"Amgen:":[515,519],"Sanofi:":[523,525],"Consultancy;":[524],"Consultancy.":[526]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-11-22T00:00:00"}